Carrie Smith Cox's Net Worth
$36.1 Million
Who is Carrie Smith Cox?
Carrie Smith Cox has an estimated net worth of $36.1 Million. This is based on reported shares across multiple companies, which include TEXAS INSTRUMENTS INC, CARDINAL HEALTH INC, Merck & Co., Inc., Organon & Co., Cartesian Therapeutics, Inc., electroCore, Inc., CELGENE CORP /DE/, and ARRAY BIOPHARMA INC.
SEC CIK
Carrie Smith Cox's CIK is 0001110753
Past Insider Trading and Trends
2011 was Carrie Smith Cox's most active year for acquiring shares with 17 total transactions. Carrie Smith Cox's most active month to acquire stocks was the month of December. 2007 was Carrie Smith Cox's most active year for disposing of shares, totalling 30 transactions. Carrie Smith Cox's most active month to dispose stocks was the month of March. 2007 saw Carrie Smith Cox paying a total of $16,534,728.00 for 1,310,100 shares, this is the most they've acquired in one year. In 2007 Carrie Smith Cox cashed out on 1,800,000 shares for a total of $28,058,550.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TEXAS INSTRUMENTS INC (TXN) Snapshot price: $159.08
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.92% | 686 |
—
|
—
| 36.49K |
Jan 25
| |||
Form 4
|
—
|
0
|
$121.46 | -$1,881,059.60 | 35.8K |
Jul 31
| |||
Form 4
| +1.63% | 574 |
—
|
—
| 35.8K |
Jan 26
| |||
Form 4
| +1.65% | 572 |
—
|
—
| 35.23K |
Jan 27
| |||
Form 4
| +1.73% | 590 |
—
|
—
| 34.66K |
Jan 28
| |||
Form 4
|
—
|
0
|
$98.98 | -$2,299,241.75 | 34.06K |
Oct 23
| |||
Form 4
|
—
|
0
|
$81.30 | -$2,620,514.64 | 34.06K |
Jul 24
| |||
Form 4
| +2.30% | 766 |
—
|
—
| 34.06K |
Jan 24
| |||
Form 4
|
—
|
0
|
$72.97 | -$1,465,852.50 | 33.3K |
Apr 29
| |||
Form 4
| +2.96% | 957 |
—
|
—
| 33.3K |
Jan 25
| |||
Form 4
| +2.89% | 907 |
—
|
—
| 32.34K |
Jan 25
| |||
Form 4
|
—
|
0
|
$52.31 | -$838,320.00 | 31.43K |
Jul 27
| |||
Form 4
| +4.18% | 1.26K |
—
|
—
| 31.43K |
Jan 26
| |||
Form 4
| +6.68% | 1.89K |
—
|
—
| 30.17K |
Jan 29
| |||
Form 4
|
—
|
0
|
$40.22 | -$413,510.00 | 135.14K |
Jul 28
| |||
Form 4
| +7.01% | 1.85K |
—
|
—
| 28.29K |
Jan 28
| |||
Form 4
| +9.39% | 2.27K |
—
|
—
| 26.43K |
Jan 23
| |||
Form 4
|
—
|
0
|
$30.28 | -$261,750.00 | 24.16K |
Jul 25
| |||
Form 4
| +14.43% | 3.05K |
—
|
—
| 24.16K |
Jan 25
| |||
Form 4
| +17.14% | 3.09K |
—
|
—
| 21.12K |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +19.07% | 2.89K |
—
|
—
| 18.03K |
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
| +19.78% | 2.5K |
—
|
—
| 15.14K |
Jan 28
| |||
Form 4
| +24.66% | 2.5K |
—
|
—
| 12.64K |
Jan 29
| |||
Form 4
| +19.78% | 1.67K |
$29.15 | $48,797.10 | 10.14K |
Apr 25
| |||
Form 4
| +41.91% | 2.5K |
—
|
—
| 8.46K |
Jan 25
| |||
Form 4
| +11.18% | 600 |
$32.88 | $19,728.00 | 5.96K |
Aug 10
| |||
Form 4
| +87.26% | 2.5K |
—
|
—
| 5.37K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| +17.42% | 425 |
$23.01 | $9,779.25 | 2.87K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
| +22.00% | 440 |
$22.94 | $10,093.60 | 2.44K |
Oct 21
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CARDINAL HEALTH INC (CAH) Snapshot price: $106.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.87% | 2.31K |
—
|
—
| 41.63K |
Nov 9
| |||
Form 4
| +10.41% | 3.71K |
—
|
—
| 39.32K |
Nov 11
| |||
Form 4
| +10.35% | 3.34K |
—
|
—
| 35.61K |
Nov 9
| |||
Form 4
| +11.87% | 3.42K |
—
|
—
| 32.27K |
Nov 12
| |||
Form 4
| +12.32% | 3.16K |
—
|
—
| 28.85K |
Nov 9
| |||
Form 4
| +11.37% | 2.62K |
—
|
—
| 25.69K |
Nov 8
| |||
Form 4
| +11.87% | 2.45K |
—
|
—
| 23.06K |
Nov 3
| |||
Form 4
| +9.85% | 1.85K |
—
|
—
| 20.62K |
Nov 4
| |||
Form 4
| +12.11% | 2.03K |
—
|
—
| 18.77K |
Nov 5
| |||
Form 4
| +18.49% | 2.61K |
—
|
—
| 16.74K |
Nov 6
| |||
Form 4
| +3.18% | 435 |
$46.25 | $20,118.75 | 14.13K |
May 14
| |||
Form 4
| +33.11% | 3.41K |
—
|
—
| 13.69K |
Nov 2
| |||
Form 4
| +45.04% | 3.19K |
—
|
—
| 10.29K |
Nov 2
| |||
Form 4
| +91.86% | 3.4K |
—
|
—
| 7.09K |
Nov 3
| |||
Form 4
|
∞
| 3.7K |
$32.46 | $120,004.62 | 3.7K |
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Merck & Co., Inc. (MRK) Snapshot price: $127.56
Executive Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -169.53K |
—
|
—
|
0
|
Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +28.46% | 37.55K |
$23.70 | -$768,946.50 | 169.53K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +44.71% | 40.77K |
$18.64 | -$656,612.64 | 131.98K |
Apr 25
| |||
Form 4
|
—
|
0
|
$25.00 | -$5,850,063.00 | 91.2K |
May 1
| |||
Form 4
|
—
|
0
|
$24.53 | -$5,693,487.00 | 91.2K |
Apr 20
| |||
Form 4
| +70.00% | 37.55K |
$21.93 | -$711,518.85 | 91.2K |
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| -46.35% | -46.35K |
$20.10 | -$931,635.00 | 53.65K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
| No matching records found | |||||||||
Organon & Co. (OGN) Snapshot price: $17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cartesian Therapeutics, Inc. (RNAC) Snapshot price: $0.641
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +83.61% | 178K |
—
|
—
| 390.88K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +156.85% | 130K |
$1.15 | $149,799.00 | 212.88K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +26.19% | 17.2K |
$2.95 | $50,664.32 | 82.88K |
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
∞
| 65.68K |
$1.46 | $95,894.26 | 65.68K |
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||